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Genetically Hypertensive Brown Norway Congenic Rat Strains Suggest 
Intermediate Traits Underlying Genetic Hypertension
Aim To determine the independent and combined effects of three 
quantitative trait loci (QTL) for blood pressure in the Genetically 
Hypertensive (GH/Omr) rat by generating and characterizing single 
and combined congenic strains that have QTL on rat chromosomes 
(RNO) 2, 6, and 18 from the GH rat introduced into a hypertension 
resistant Brown Norway (BN) background.
Methods Linkage analysis and QTL identification (genome wide 
QTL scan) were performed with MapMaker/EXP to build the genetic 
maps and MapMaker/QTL for linking the phenotypes to the genetic 
map. The congenic strains were derived using marker-assisted selec-
tion strategy from a single male F1 offspring of an intercross between 
the male GH/Omr and female BN/Elh, followed by 10 generations of 
selective backcrossing to the female BN progenitor strain. Single con-
genic strains generated were BN.GH-(D2Rat22-D2Mgh11)/Mcwi 
(BN.GH2); BN.GH-(D6Mit12-D6Rat15)/Mcwi (BN.GH6); and 
BN.GH-(D18Rat41-D18Mgh4)/Mcwi (BN.GH18). Blood pressure 
measurements were obtained either via a catheter placed in the femoral 
artery or by radiotelemetry in the single and combined congenics. Re-
sponses to angiotensin II (ANGII), norepinephrine (NE), and barore-
ceptor sensitivity were measured in the single congenics.
Results Transferring one or more QTL from the hypertensive GH into 
normotensive BN strain was not sufficient to cause hypertension in any 
of the developed congenic strains. There were no differences between 
the parental and congenic strains in their response to NE. However, 
BN.GH18 rats revealed significantly lower baroreceptor sensitivity 
(β = -1.25 ± 0.17), whereas BN.GH2 (β = 0.66 ± 0.09) and BN.GH18 
(β = 0.71 ± 0.07) had significantly decreased responses to ANGII from 
those observed in the BN (β = 0.88 ± 0.08).
Conclusion The failure to alter blood pressure levels by introducing 
the hypertensive QTL from the GH into the hypertension resistant 
BN background suggests that the QTL effects are genome background-
dependent in the GH rat. BN.GH2 and BN.GH18 rats reveal signifi-
cant differences in response to ANGII and impaired baroreflex sensi-
tivity, suggesting that we may have captured a locus responsible for the 
genetic control of baroreceptor sensitivity, which would be considered 
an intermediate phenotype of blood pressure.
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It is widely known that genetic factors play an 
important role in the onset and progression of 
hypertension and hypertension-induced end-
organ damage in humans (1). As with all com-
mon multifactorial diseases, identifying the ge-
netic components of hypertension in humans 
is complicated by allelic, locus, and epidemio-
logical heterogeneity, as well as by a significant 
environmental component (2,3). Heritabili-
ty measures for human essential hypertension 
range from 15%-60% (4,5). Main approach-
es used to dissect genetics of hypertension in-
clude linkage analysis in families with hyper-
tension, linkage studies in affected sib-pairs, 
and candidate gene and genome-wide associa-
tion studies in candidate genes (6,7). Howev-
er, with the exception of rare monogenic forms 
of hypertension such as Liddle’s syndrome (8), 
the syndrome of apparent mineralocorticoid 
excess (9), and glucocorticoid remediable aldo-
steronism (10), identification of the major ge-
netic factors of essential hypertension remains 
elusive (11). In addition to genome-wide scans 
and association studies, the use of “interme-
diate” phenotypes is a relatively common tool 
proposed to help unravel the genetic basis of 
hypertension. Unfortunately, despite wide-
spread discussion of using “intermediate” phe-
notypes (12,13), there is little hard evidence 
that they exist (14). Often what is thought 
to be an intermediate phenotype is in itself a 
complex trait (15,16).
Several inbred hypertensive rat strains have 
been independently developed to mimic vari-
ous aspects of the pathogenesis of human hy-
pertension (17), with the expectation that the 
reduced heterogeneity in the rat will facilitate 
quantitative trait loci (QTL) and gene identi-
fication, which can then be followed-up in hu-
mans. In this study, we investigated the Genet-
ically Hypertensive rat (GH/Omr). The GH 
rat was the first genetically inbred rat model 
for hypertension, characterized by early onset 
of hypertension (by the age of 6 weeks), hyper-
cholesterolemia, cardiac hypertrophy, and vas-
cular disease (18).
Here we report the first complete genome 
linkage scan of hypertension and related traits 
in the GH rat and results of the initial physi-
ological characterization of the single, double, 
and triple congenics, in comparison with the 
parental GH and BN strains.
Material and methods
Animals
All breeding for the linkage studies was done 
at the University of Otago Animal Breeding 
Station, as previously described by Harris et al 
(19), under approved animal protocols. Breed-
ing for physiological characterization in single, 
double, and triple congenics was done at the 
Animal Research Center of the Medical Col-
lege of Wisconsin (MCW), Milwaukee, WI, 
USA. Animals were housed in standard rat 
cages with lights in the Animal Care Facility 
on from 6:00 am to 6:00 pm, which was ap-
proved by the American Association for the 
Accreditation of Laboratory Animal Care. All 
protocols were approved by the Medical Col-
lege of Wisconsin’s Animal Welfare Commit-
tee. Standard commercial rat chow (LabDiet 
chow – Purina Mills, Virginia, USA, catalog 
No. 5001, 0.4% NaCl) and drinking fluid (tap 
water) were provided ad libitum.
Construction of single congenic animals 
was initiated in New Zealand, derived from 
a single male F1 offspring of an intercross be-
tween the male GH/Omr and female BN/Elh 
(19). The male F1 offspring was then back-
crossed to a female BN. Partially congenic rats 
were exported to Charles River Laboratories, 
Wilmington, MA, USA, for cesarean rederi-
vation and then sent to MCW in 1999. The 
initial congenic strains were developed after 
10 generations of selective backcrossing to the 
female BN progenitor strain, followed by a fi-
nal intercross to fix the QTL segment of GH 
Croat Med J 2008;49:586-599
588
genome. The size of introgressed segment was 
finally determined by genotyping using se-
lected simple sequence length polymorphisms 
(SSLPs). We tested each strain with 112 ge-
netic markers distributed across the genome 
to ensure the genome background was that of 
the BN rat. All congenics were maintained by 
brother/sister mating. The double and triple 
congenics were derived at MCW by intercross-
ing single congenics. We used a marker-assist-
ed selection strategy to build the single and 
double congenic strains (20-22) and screened 
SSLPs within and by flanking the 99% confi-
dence interval for each of the blood pressure 
QTL.
Genotyping
Genomic DNA was extracted from the tail 
tips of the backcross and intercross progeny by 
standard methods (23). The DNA was diluted 
to 5 ng/µL stocks in sterile, distilled water. Ge-
notyping with SSLPs was performed using ra-
dioactive P32 labeled markers as previously de-
scribed (24).
Genetic mapping
We performed a total genome scan using 260 
SSLPs markers corresponding to approxi-
mately one marker every 5.6 centiMorgan 
(cM) by a two step linkage analysis strate-
gy. Initially, we performed a genome scan us-
ing the 46 most phenotypically divergent and 
informative F2 animals to identify putative 
QTL. The putative QTL were then validated 
by genotyping the remaining 61 animals with 
all markers in the regions of interest and re-
analyzing linkage with all animals. Prior to 
the linkage analysis, the distribution of the 
phenotypes in the F2 population was tested 
for normality using a Kolmogorov-Smirnov 
test (25). Traits failing to meet the require-
ments of normality were transformed using 
either square root transformation or loga-
rithmic transformation and retested for nor-
mality. Normally distributed phenotypes 
(following transformation, if necessary) 
were mapped with parametric linkage analy-
sis (26,27). Traits that were not successfully 
transformed to normality were analyzed with 
nonparametric linkage analysis using untrans-
formed data (28). With this methodology, we 
minimized the risk of high false-positive re-
sults associated with linkage analysis of non-
normal trait data, as suggested by Kruglyak et 
al (26,28). Of the six phenotypes measured in 
the F2 population, only relative left ventricu-
lar mass (LVM) was analyzed using nonpara-
metric statistics.
Linkage analysis and QTL identification 
were performed with MapMaker/EXP to 
build the genetic maps and MapMaker/QTL 
for linking the phenotypes to the genetic map, 
as previously described (29,30). For the para-
metric linkage test, suggestive and signifi-
cant of 2.8 and 4.3 were accepted, respective-
ly. For the nonparametric analysis, a threshold 
of significance was determined at Z score ≥3.5 
(27). In a previous study in our laboratory us-
ing a similar sized F2 population and almost 
20 times the number of measured phenotypes, 
permutation testing confirmed that these 
thresholds were appropriate (25).
Analysis of multiple QTL effects
Additional analyses were performed to de-
termine whether the QTLs identified in the 
above analysis were a result of additive or 
non-additive interaction effects. MapMak-
er files (.raw and .maps files) were imported 
into the rQTL software package (31). Inter-
val mapping was performed in rQTL to con-
firm the blood pressure QTL identified using 
MapMaker/QTL. The “scantwo” function 
within rQTL was then used to test for pair-
wise effects between all loci. This analysis de-
termines LOD scores for five models between 
loci as follows: full (additive + epistatic [in-
teraction] effects); interaction; additive; and 
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conditional-interactive and additive, which 
compare the interactive and additive effects to 
a single QTL. Significance thresholds, as sug-
gested for an F2 intercross within the rQTL 
tutorial, are 9.1, 7.1, 6.3, 6.3, and 3.3 for full, 
conditional-interactive, interaction, additive, 
and conditional-additive LOD scores, respec-
tively (31).
Phenotyping for genome scan
All phenotypes for the F2 animals were gener-
ated at the University of Otago and published 
previously as a candidate gene report (19). 
Briefly, 107 male F2 rats were obtained and 
the following phenotypes determined at age 
of 18 ± 1 weeks. Systolic blood pressure (SBP) 
was measured indirectly in all 107 F2 males 
using the tail-cuff method, as described else-
where (18). Two or 3 independent measure-
ments were made over a period of one week 
and the mean value was calculated. One day 
after the last tail-cuff measurement, intra-arte-
rial blood pressure and pulse rate were deter-
mined directly via a catheter placed in the ca-
rotid artery under light anesthesia, after which 
the rat was killed. Its biometric phenotypes 
were measured and body weight, LVM, and 
relative LVM (mg/g body weight) were de-
rived from these measurements.
Phenotyping for single congenic rats
To select the sub-phenotypes (phenotypes hy-
pothesized to be intermediate phenotypes) 
to be screened in the congenic rats, we used 
the data set from the PhysGen (http://pga.
mcw.edu) Program for Genomic Applica-
tions. PhysGen had tested the GH and BN 
(although a different substrain of BN) for 
279 heart, lung, and blood traits. Informa-
tion from this data set guided our decision to 
challenge the hemodynamic and vasopressor 
functions of these animals by studying the ef-
fects of potent stressors, such as angiotensin 
II (ANG II) and norepinephrine (NE). Fur-
thermore, we selected several biometrical mea-
surements that were significantly different be-
tween the GH and BN in the PhysGen data. 
These sub-phenotypes were selected because 
they are potential intermediate phenotypes 
of blood pressure. Differences in these phe-
notypes in congenic BN.GH strains encom-
passing blood pressure QTL would suggest 
that they may indeed be intermediate pheno-
types (32). After preliminary physiological as-
sessment, we noticed that one of the congenic 
strains (BN.GH18) had a potentially impaired 
baroreceptor activity. Therefore, to assess baro-
receptor sensitivity under the same premise, 
we also used bolus doses of phenylephrine, as 
previously described (33).
The following protocol was performed in 
16-21 males from each single congenic and pa-
rental strains. At the age of 18 ± 1 weeks, mi-
crorenathane catheters were implanted in the 
left femoral artery and vein for blood pres-
sure measurements using the procedure de-
scribed by Cowley et al (34). After one week 
of recovery from surgery, catheters were con-
nected to transducers (Argon Medical Tech-
nologies, Athens, TX, USA) interfaced with 
a computerized data acquisition system; then 
SBP, diastolic blood pressure (DBP), mean ar-
terial pressure (MAP), and heart rate (HR) 
were recorded at a frequency of 300 HZ for 4 
hours per day for the first three days in the an-
imal’s home cage. SBP, DBP, MAP, and HR 
were averaged over 1-minute periods and con-
verted to a mean daily value for the record-
ing session. The daily averages of MAP, SBP, 
DBP, and HR for each animal were reduced 
to a single value for the 3-day recording peri-
od. On day 4, we began the challenges using 
the vasoactive compounds ANGII and NE, 
both of which were obtained from Sigma (St. 
Louis, MO, USA) and administered IV us-
ing infusion pumps (Harvard Apparatus Inc, 
Holliston, MA, USA). On day 4, SBP, DBP, 
MAP, and HR were measured during contin-
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uous infusion of ANG II at 4 different doses 
(day (D)1 = 5 ng/kg/min, D2 = 10˝ng/kg/
min, D3 = 25 ng/kg/min, and D4 = 50 ng/kg/
min) with each dose period of 15 minutes in 
duration. On day 5, SBP, DBP, MAP, and HR 
were measured during continuous infusion of 
NE, at 4 different doses (D1 = 0.1 μg/kg/min, 
D2 = 0.2 μg/kg/min, D3 = 0.5 μg/kg/min, and 
D4 = 1.0 μg/kg/min) with each dose period of 
15 minutes in duration. SBP, DBP, MAP, and 
HR were averaged over 1-minute periods and 
converted to a mean 15-minute value for the 
recording session for each dose of ANGII and 
NE. This protocol was previously used and 
published (http://pga.mcw.edu). On day 6, ar-
terial baroreceptor sensitivity was determined 
by modified Oxford method (33), recording 
SBP and HR first 30 seconds after IV bolus 
doses of phenylephrine (0.1 ml, 4 μg/kg), ob-
tained from Sigma.
On the last day of the experiment, ani-
mals were killed with CO2 and organs (kid-
ney, heart) were harvested and weighed. Body 
weight was also measured.
Measurement of blood pressure in double and 
triple congenics
Blood pressure was measured in BN, GH, and 
double and triple congenic strains by radiote-
lemetry using the Dataquest IV system (Data 
Sciences Inc, St. Paul, MN, USA). Rats were 
anesthetized with 1% isoflurane and a femo-
ral catheter was implanted in the left femo-
ral artery. The telemetry catheter is attached 
to a TA11PA-C40 radio-telemetry transmit-
ter, which was placed subcutaneously in the 
back of the rat. Rats were placed in individ-
ual cages after 3 days of recovery from sur-
gery; blood pressure was measured for three 
days during a low salt diet (0.4% NaCl). Rats 
where then switched to a 4% NaCl diet and 
blood pressure was measured every other day 
for 23 days. Blood pressure was measured for 
10 seconds every two minutes for a total of 
four hours on each experimental day and av-
eraged after discarding the first 30 minutes of 
recording. The daily averages of blood pres-
sure were reduced to a single value for the re-
cording period.
Statistical analysis
All data are presented as mean ± standard de-
viation unless stated otherwise. Baseline SBP, 
DBP, MAP, and HR data were evaluated by 
analysis of variance (ANOVA) with a post-hoc 
analysis using Dunnett test (multiple compari-
sons vs control BN group) (SigmaStat, version 
2.03; SPSS Inc., Chicago, IL, USA).
Vascular reactivity data (NE and ANG 
II) were fit to linear regression equations: 
VR = α0 + β[x], where VR is vascular reactivi-
ty, α0 is an intercept term, [x] is drug concen-
tration, and β is slope coefficient. The t sta-
tistic for the slope was significant at the 0.05 
critical α level. For all regression equations, r2 
was >0.80, ie, it explained more than 80% of 
the variance in the dependent variable by the 
regression equation. We defined β (slope) co-
efficient as the reactivity index representing 
the change in mean blood pressure for an in-
cremental change in the independent variable 
(NE and ANG II concentration), as previous-
ly described (35,36).
Heart rate response to SBP changes (a 
measure of baroreflex sensitivity) caused by 
phenylephrine bolus doses was recorded and 
linear regression analysis was performed, 
whereby slope coefficients (β) of each animal’s 
regression line were averaged and taken as an 
index of baroreceptor sensitivity (33). NE, 
ANG II, baroreceptor sensitivity, and slope 
coefficients were separately evaluated by anal-
ysis of variance (ANOVA) followed by Dun-
nett test. In all cases, a value of P ≤ 0.05 was 
considered to be statistically significant. All 
statistical analyses were performed with Sig-
maStat, version 2.03 (SPSS Inc., Chicago, IL, 
USA)




The genome size in this cross was calculated 
to be 1412.4 cM, consistent with previous-
ly published maps obtained in other linkage 
analysis studies using male F2 populations and 
ranging from 1509 cM (37) to 1749 cM (38) 
to 1831 cM (39). In our study, genome cov-
erage averaged every 5.4 cM. In total, 8 QTL 
were assigned to the genetic map (five signifi-
cant with LOD score ≥4.3 and three sugges-
tive with LOD≥2.8), corresponding to five of 
six measured phenotypes (tail blood pressure, 
intra-arterial blood pressure, body weight, 
LVM, and relative LVM) (Table 1). Overlap-
ping QTL regions for blood pressure mapped 
to chromosomes 2, 6, and 18 were identified 
in other crosses involving other hypertensive 
strains, suggesting that these loci are likely to 
exhibit true linkage. The QTL for blood pres-
sure on chromosome 6 was identified by both 
the direct and indirect measurements of blood 
pressure, further supporting the existence of a 
blood pressure regulating gene(s) at this loca-
tion. Furthermore, body weight was mapped 
to a region of chromosome 3 (LOD 5.2); 
LVM was mapped to chromosomes 3 and 13 
(LOD 4.6 and 4.1, respectively), while relative 
LVM was mapped to chromosome 10 only 
(LOD 4.6). Heart rate was not mapped in this 
cross.
Additive and epistatic QTL
Table 2 displays the results from the scan two 
analysis for the tail-cuff blood pressure QTL 
on chromosomes 2, 6, and 18. All pairwise 
comparisons showed significant full LOD 
scores, which reflect both additive and inter-
active effects. However, there is no evidence 
for significant pairwise interactions for any of 
the loci, although a non-significant trend for 
interaction was seen between chromosomes 
2/18 and 2/6. Moreover, there is significant 
evidence for additive effects for all three pair-
wise comparisons. From this data, we hypoth-
esized that single congenic strains should sig-
nificantly affect blood pressure.
Results from studying the congenics
Genome characterization. The blood pressure 
QTL were followed up by generating three 
congenics, in which each blood pressure QTL 
from GH was introgressed onto the genome 
background of the normotensive BN (Figure 
1). In each case, we attempted to capture the 
Table 1. Quantitative trait loci (QTL) mapped in an F2 intercross between Genetically Hypertensive (GH) and Brown Norway (BN) rats
No. Traits Chromosome No. Flank1 Flank2 LOD* Size (cM) Peak
1 Tail cuff blood pressure (mm Hg)  2 D2Mgh7 D2Mgh12 3.58† 25.8 D2Mgh8
2 Tail cuff blood pressure (mm Hg)  6 D6Mit12 D6Mit3 4.30‡ 73.4 D6Mit9
3 Tail cuff blood pressure (mm Hg) 18 D18Mgh4 D18Mgh2 4.05† 19.5 D18Mgh6
4 Left ventricle mass (mg)  3 D3Mgh21 D3Mgh2 4.63‡ 48.4 D3Mit4
5 Left ventricle mass (mg) 13 D13mgh13 D13Kid1 4.12† 34.6 D13Arb7
6 Direct blood pressure (mm Hg)  6 D6Pas1 D6Mit3 4.80‡ 71.9 D6Mit9
7 Body weight (g)  3 D3Mgh21 D3Mgh2 5.19‡ 48.4 D3Mit4
8§ Relative left ventricle mass (mg/g) 10 D10Mit6 D10Mit7 4.55‡ 22.5 D10Mgh8
*LOD – log10 of the odds.
†Suggestive linkage.
‡Significant linkage.
§Mapped with nonparametric linkage analysis.















6; 34 18; 15 9.86† 5.08 0.72 9.13† 4.35†
2; 42 18; 14 9.37† 5.58 1.70 7.67† 3.88†
2; 42  6; 33 9.50† 4.72 1.83 7.67† 2.89
*Abbreviations: RNO – rat chromosomes, LOD – log10 of the odds.
†Significant, based upon 10 000 simulations of crosses with 250 individuals, markers at a 10 cM spacing, and analysis by Haley-Knott regression (31).
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99% confidence interval. To confirm the con-
genics were isogenic, we scanned the genome 
with 112 polymorphic markers ( ~ 1 marker 
per 20 cM). All markers were homozygous for 
BN, demonstrating that passenger loci from 
the GH are likely to be few. All QTL encom-
passed a large chromosomal interval, based on 
the genomic sequence of the rat: 127.71 Mb 
for chromosome 2, 101.86 Mb for chromo-
some 6, and 20.3 Mb for chromosome 18; con-
sequently, the congenic regions were scanned 
more densely, approximately one marker ev-
ery 8-10 cM. For the BN.GH6 and BN.GH18 
congenics, we captured the complete QTL 
confidence interval. For the BN.GH2 con-
genic, 14 Mb was excluded due to a misplaced 
marker in previous genetic maps. The double 
congenic and triple congenic animals had the 
same introgressed regions as the single congen-
ic animals.
Baseline blood pressure
Initially, five groups of animals (GH, 
BN.GH2, BN.GH6, BN.GH18, and BN) 
were studied. Despite carrying a QTL for hy-
pertension, none of the blood pressure or 
heart rate phenotypes in any of the three sin-
gle congenics differed from the BN (Table 3). 
GH rats had significantly higher MAP than 
BN and all of the single congenics strains. 
Consequently, transferring a single QTL from 
the hypertensive GH onto the normotensive 
BN strain was not sufficient to cause a signif-
icant increase in baseline blood pressure. This 
could be due to genetic factors on the BN ge-
nome that are highly resistant to hypertension, 
due to epistatic relationships between blood 
pressure QTL, or due to a threshold effect (ie, 
multiple QTL are required to overcome ho-
meostasis on a resistant genome background). 
Because the QTL analysis did not indicate sig-
nificant interactions between QTL, we hy-
pothesized there was a possible threshold ef-
fect and, therefore, measured blood pressure 
in double and triple congenics using telemetry 
monitoring. Unfortunately, none of the dou-
ble or the triple congenic strains was sufficient 
to significantly increase blood pressure on the 
BN background, even after exposure to a high 
salt diet (Table 4).
Biometric measurements
To assess end organ damage in the congenics, 
heart and kidney weights (absolute and nor-
malized by body weight) were determined in 
the single congenic and parental strains (Ta-
ble 5). It is not surprising that the congenics 
showed no differences in kidney measures as 
they also did not significantly differ between 
BN and GH. Although the GH have a sig-
nificantly higher absolute and adjusted heart 
weight than BN, we did not observe any sig-
nificant differences in the congenics compared 
with the BN parental control, indicating that 
hypertrophy requires hypertension as a driver 
or may be under different genetic control than 
blood pressure in the GH. However, indepen-
dent genetic factors causing cardiac hypertro-
phy would not necessarily be surprising, as the 
QTL for LVM and left ventricular hypertro-
Figure 1. Genetic maps superimposed on the genomic sequence of rat chromosomes 
2, 6, and 18 with blood pressure quantitative trait loci (BP QTL), congenic regions, and 
flanking markers. Checker board filled lines represent introgressed BP QTL regions, 
horizontal bars are flanking markers used to construct the congenics. It is important to 
note that these congenics were generated long before there was genomic sequence to 
firmly establish genetic order or genetic distances. The brackets denote the mapped QTL 
(99% confidence interval).
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phy were mapped to different loci in the F2 
intercross.
NE and ANGII challenge
The cardiovascular system of the rats was 
challenged with NE and ANG II to identify 
additional sub-phenotypes (phenotypes hy-
pothesized to be intermediate phenotypes of 
hypertension). Animals were tested with four 
different doses of each vasoconstrictor, rang-
ing from 0.1 to 1.0 μg/kg/min (NE) and from 
5 to 50 ng/kg/min (ANG II). The changes in 
mean arterial pressure caused by administra-
tion of NE and ANG II were fitted to linear 
regression equations and we calculated β coef-
ficients (slope) for each of strains (11-14 rats 
in each group). The β coefficients (slope) of 
blood pressure responses to NE and ANG II 
are summarized in Table 6. We did not find 
any differences in the β coefficient after ad-
ministration of NE (Figure 2). However, two 
congenic strains, BN.GH2 and BN.GH18 
Table 3. Baseline mean arterial pressure, systolic blood pressure, diastolic blood pressure, and heart rate values in single congenic 
and parental strains*
Rat strain (mean ± standard deviation)
Trait GH (n = 21) BN.GH2 (n = 19) BN.GH6 (n = 16) BN.GH18 (n = 21) BN (n = 21)
Mean arterial pressure (mm Hg) 155.7 ± 14† 103.8 ± 9.2  97.3 ± 11  98.0 ± 6.7  99.8 ± 10.0
Systolic blood pressure (mm Hg) 190.9 ± 9.7† 124.6 ± 7.4 114.4 ± 9.5 116.7 ± 6.9 116.4 ± 7.8
Diastolic blood pressure (mm Hg)‡ 129.5 ± 15†  86.9 ± 9.7  82.7 ± 12  82.6 ± 8.3  85.3 ± 12.0
Heart rate (beats per minute) 365.0 ± 23.0 349.8 ± 32.0 381.3 ± 32.0 361.7 ± 33.0 362.0 ± 32.0
*Abbreviations: GH – Genetically Hypertensive rats; BN – Brown Norway rats; BN.GH2 – BN.GH-(D2Rat22-D2Mgh11)/Mcwi; BN.GH6 – BN.GH-(D6Mit12-D6Rat15)/Mcwi; and 
BN.GH18 – BN.GH-(D18Rat41-D18Mgh4)/Mcwi
†P < 0.05 vs BN. All data were evaluated by analysis of variance (ANOVA) with a post-hoc analysis using Dunnett test (multiple comparisons vs control BN group).
‡Measured using an intra-arterial catheter.
Table 4. Mean arterial pressure in double and triple congenic and parental rat strains
Rat strain (mean ± standard deviation)
Trait GH (n = 20) BN.GH2.6 (n = 16) BN.GH6.18 (n = 16) BN.GH2.18 (n = 16) BN.GH2.6.18 (n = 16) BN (n = 21)
Mean arterial pressure (mm Hg) 
 on 4% NaCl diet
147.5 ± 9.2† 98.1 ± 7.9 99.5 ± 10.4 110.1 ± 7.8 93.5 ± 8.6 93.0 ± 9.3
*Abbreviations: GH –Genetically Hypertensive rats; BN – Brown Norway rats; BN.GH2 – BN.GH-(D2Rat22-D2Mgh11)/Mcwi; BN.GH6 – BN.GH-(D6Mit12-D6Rat15)/Mcwi; and 
BN.GH18 – BN.GH-(D18Rat41-D18Mgh4)/Mcwi.
†P < 0.05 vs BN, all values were calculated by analysis of variance (ANOVA) with a post-hoc analysis using Dunnett test (multiple comparisons vs control BN group).
Table 5. Biometric measurements in single congenics and parentals*












Kidney weight (g)  1.22 ± 0.05  1.15 ± 0.15  1.12 ± 0.2 1.17 ± 0.2  1.12 ± 0.10
Adjusted kidney weight per 100 g of body weight (g/100 g)  0.34 ± 0.02  0.37 ± 0.03  0.37 ± 0.04 0.38 ± 0.04  0.36 ± 0.04
Left ventricular mass (g)  1.69 ± 0.13†  1.13 ± 0.15  1.17 ± 0.23 1.15 ± 0.20  1.15 ± 0.13
Left ventricular hypertrophy (cardiac hypertrophy) per 100 g of body weight (g/100 g)  0.47 ± 0.07†  0.34 ± 0.05  0.38 ± 0.03 0.37 ± 0.03  0.37 ± 0.06
Body weight (g) 365.4 ± 17.0† 330.6 ± 26.0 299.9 ± 39.0 315.2 ± 24.0 310.3 ± 35.0
*Abbreviations: GH – Genetically Hypertensive rats, BN – Brown Norway rats; BN.GH2 – BN.GH-(D2Rat22-D2Mgh11)/Mcwi; BN.GH6 – BN.GH-(D6Mit12-D6Rat15)/Mcwi; and 
BN.GH18 – BN.GH-(D18Rat41-D18Mgh4)/Mcwi.
†P < 0.05 vs BN. All data were evaluated by analysis of variance (ANOVA) with a posthoc analysis using Dunnett test (multiple comparisons vs control BN group).
Table 6. The β coefficients (slope) of blood pressure responses to angiotensin II and norepinephrine in single congenic and Brown 
Norway (BN) negative controls*†
β coefficients in rat strain (mean ± standard deviation)
Drug GH (n = 14) BN.GH2 (n = 11) BN.GH6 (n = 11) BN.GH18 (n = 11) BN (n = 14)
Norepinephrine 0.34 ± 0.10‡ 0.28 ± 0.9 0.19 ± 0.8 0.26 ± 0.11 0.28 ± 0.05
Angiotensin II 0.48 ± 0.08‡ 0.66 ± 0.09‡ 0.86 ± 0.08 0.71 ± 0.07‡ 0.88 ± 0.08
*Abbreviations: GH – Genetically Hypertensive rats; BN – Brown Norway rats; BN.GH2 – BN.GH-(D2Rat22-D2Mgh11)/Mcwi; BN.GH6 – BN.GH-(D6Mit12-D6Rat15)/Mcwi; and 
BN.GH18 – BN.GH-(D18Rat41-D18Mgh4)/Mcwi.
†The β coefficients (slope) in the congenics and the parental rats are estimates of the vascular responsiveness: the higher the β coefficient, the greater the rate of change in response 
to the vasoactive agent.
‡P < 0.05 vs BN. All data were evaluated by analysis of variance (ANOVA) with a post-hoc analysis using Dunnett test (multiple comparisons vs control BN group).
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(Figure 3), had significant differences in their 
blood pressure response to ANG II than that 
of the parental BN strain, indicating that 
these congenic strains may harbor a gene(s), 
which affect their response to this vasocon-
strictor.
Baroreceptor reflex sensitivity
After analyzing heart rate response to ANG 
II, we found that only one congenic strain, 
BN.GH18, had a response different from BN, 
which was consistent with previous findings 
of baroreceptor QTL on chromosome 18 in 
SS rats (25). This finding prompted us to test 
baroreceptor sensitivity using bolus doses of 
phenylephrine (IV) in BN.GH18 and paren-
tal controls. Phenylephrine was given to pro-
duce sudden blood pressure increases and the 
resulting decreases in heart rate were measured 
as previously described (33). Linear regression 
analysis was used to calculate the β coefficients, 
which is a common index of baroreceptor sen-
sitivity. BN.GH18 (N = 11) rats revealed sig-
nificantly lower baroreceptor sensitivity com-
pared with the BN (N = 14) normotensive 
control (β = -1.25 ± 0.17 vs β = -2.28 ± 0.26); 
P < 0.005). This baroreceptor reflex activity 
was also abnormal in GH (N = 14) compared 
with BN rats (β = -0.87 ± 0.25, P < 0.001), sug-
gesting that absence or impairment of the re-
flex may be an important blood pressure sub-
phenotype mapped to the chromosome 18 
QTL.
Discussion
The present study represents a first complete 
genome-wide scan for linkage to hyperten-
sion and hypertension-induced end-organ 
damage in the GH rat strain. While asso-
ciations between some cardiovascular phe-
notypes and several candidate gene alleles 
(GCA, REN, TNF α) in GH rats have al-
ready been reported in a GH × BN intercross 
(19,40,41), we report, for the first time, all 
data and results of the complete genome scan 
including QTL for five of the six measured or 
derived traits on six different chromosomes. 
Three major blood pressure QTL in the GH 
rat were identified (1 significant QTL on 
chromosome 6 and 2 suggestive on chromo-
somes 2 and 18). Furthermore, we mapped 
two QTL for LVM, one concurrent with a 
Figure 2. Blood pressure response to norepinephrine (NE) x-axis 
shows different concentration of administered drugs as follows: 1 = 0.1 
μg/kg/min, 2 = 0.2 μg/kg/min, 3 = 0.5 μg/kg/min, and 4 = 1.0 μg/kg/min. 
y-axis shows calculated mean delta mean arterial pressure value be-
tween 10th and 15th minute of infusion. BN.GH2 (n = 11) – doted line, 
BN.GH6 (n = 11) – full line, BN.GH18 (n = 11) – dasehs line, and BN 
(n = 14) – bold line. Lines represent linear regression lines (slopes) for 
each group. All data were evaluated by analysis of variance (ANOVA) 
with a post-hoc analysis using Dunnett test (multiple comparisons vs 
control BN group).
Figure 3. Blood pressure response to angiotensin II (ANGII). x-axis 
shows different concentration of administered drugs as follows: 1 = 5 
ng/kg/min, 2 = 10 ng/kg/min, 3 = 25 ng/kg/min, and 4 = 50 ng/kg/min. y-
axis shows calculated mean delta mean arterial pressure (MAP) value 
between minutes 10 and 15 of infusion. BN.GH2 (n = 11) – dashed 
line, BN.GH6 (n = 11) – full line, BN.GH18 (n = 11) – doted line, and BN 
(n = 14) – bold line. Lines represent linear regression lines (slopes) for 
each group. MAP responses to ANGII were significantly enhanced in 
BN.GH2 and BN.GH18 rats compared with control. P < 0.05 BN.GH2 
vs BN; P < 0.05 BN.GH18 vs BN. All data were evaluated by analysis 
of variance (ANOVA) with a post-hoc analysis using Dunnett test (mul-
tiple comparisons vs control BN group).
Bilusic et al: Phenotyping of BN.GH Congenic Rats
595
body weight QTL, and one QTL for left ven-
tricular hypertrophy.
To follow up the blood pressure QTL, we 
initially constructed single congenic strains for 
each of those three regions, introgressing the 
susceptible GH allele onto the genome back-
ground of the resistant BN rat. Overall, the 
phenotypic data showed that the transfer of 
any one of the QTL regions (chromosome 2, 
6, or 18) from GH onto BN background was 
not sufficient to independently induce hyper-
tension. A likely explanation of our results is 
the protective phenotypic effect of the BN ge-
nome background in the presence of a hyper-
tension QTL. Although it is possible that the 
initial linkage analysis captured weak QTL ef-
fects (since QTL on chromosomes 2 and 18 
had only suggestive LOD scores (LOD 3.6 
and 4.1, respectively), it is unlikely that all 
three loci would be false positives given that 
the linkage data identified a QTL on chro-
mosome 6 above the significance threshold of 
LOD 4.2 both by indirect and direct blood 
pressure measurements; that the pairwise anal-
ysis indicated significant LOD scores for chro-
mosomes 2, 6, and 18; and that the litera-
ture reports several coinciding blood pressure 
QTL in different F2 intercrosses on chromo-
somes 2 (SHR × WKY; SHR × BN; SS × BN; 
LN × LH; S × WKY; S × MNS; SS × WKY; 
SHRSP × WKY) (18,42-47), chromo-
some 6 (SS × BN) (25), and chromosome 18 
(SHR × BB/OK and BN × SS) (25,48,49). 
Although possible, it is also unlikely that the 
shorter congenic interval introgressed in the 
BN.GH2 resulted in protection from hyper-
tension.
The approach of transferring a “disease” al-
lele onto a “normal” background has worked 
in some instances and not in others (50,51). 
Likely, this is due to background strain dif-
ferences. For instance, Bianchi and Tripodi 
(51) transferred a hypertension QTL from 
the MHS onto the normotensive MNS back-
ground and observed a significant blood pres-
sure increase. However, these strains are ge-
netically much more similar than are GH and 
BN (62% similar vs 28% similar, respectively, 
according to genotype information of near-
ly 4500 SSLP markers) (http://rgd.mcw.edu/
strains/poly_table0bp.shtml) (52); it is quite 
likely that they share similar modifiers or ad-
ditional QTL as well. However, given differ-
ent strains, we and others have found that 
transferring a single disease locus onto a resis-
tant background is sometimes not sufficient 
to trigger the onset of polygenic diseases, such 
as hypertension, due to epistatic interaction 
with other QTL or due to multiple genetic 
modifiers present in the hypertensive strain 
(53,54). The advantage of introgressing a dis-
ease allele onto a “normal” background allows 
the exclusion of the influence of a susceptible 
genome background to explain individual ef-
fect of gene(s) in the regions of interest. This 
question cannot be addressed by the recipro-
cal congenic schema, ie, introgressing a nor-
mal allele into a susceptible genome back-
ground. Initial findings prompted us to test 
our hypothesis that more than one QTL is re-
quired to affect blood pressure in the congen-
ic GH.BN congenics, by generating and char-
acterizing double and triple congenic strains, 
again without confounding background ef-
fects. Unfortunately, we were not able to de-
tect any blood pressure effects in the double 
and triple congenic strains. Potentially the 
BN is not normotensive, but hypertension re-
sistant. Therefore, even three significant QTL 
from the GH rat, introgressed onto the BN 
genome, are insufficient to overcome the ho-
meostatic pressures in the BN rat. The con-
genics we developed could be used to test this 
hypothesis by performing an F2 intercross be-
tween the congenic (single, double, or triple) 
strains and the GH rat. This approach would 
allow us to map “resistance genes” in the BN 
background or modifier genes in the GH ge-
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nome, while keeping the blood pressure QTL 
fixed for the GH allele.
Our study design also allowed us to ask if 
we could detect phenotypic differences in pu-
tative intermediate phenotypes in the absence 
of a change in blood pressure. Our hypothesis 
predicted we would find sub-phenotypes relat-
ed to blood pressure regulation that would be 
altered in the congenic animals, even though 
they were all normotensive. To test this, we 
challenged the single congenic and parental 
strains pharmacologically using NE and AN-
GII, each of which increases blood pressure, 
but by different mechanisms. We found that, 
despite normal levels of blood pressure, some 
of our congenics showed different respons-
es to the vasopressor actions of ANGII, sug-
gesting it could be an intermediate pheno-
type in the BN.GH2 and BN.GH18. Since 
we previously mapped the baroreceptor reflex 
to chromosome 18 (25), although in a differ-
ent rat strain (SS rat), we decided to test only 
BN.GH18 congenic for baroreceptor sensi-
tivity because of the reduced heterogeneity as 
compared with an F2 intercross between SS 
and BN. This study showed that BN.GH18 
rats had a significantly lower baroreceptor re-
flex response, compared with normotensive 
BN controls, suggesting that we may have 
captured a major locus responsible for altered 
baroreceptor sensitivity. Several studies sug-
gest that baroreflex function is strongly in-
fluenced by genetic factors (55,56), but the 
level of the genetic contribution is not com-
pletely known (57). Given that many studies 
suggest that baroreflex abnormalities are an 
important contributing factor to the patho-
genesis of hypertension (58-62), we consider 
this result to suggest that baroreceptor sensi-
tivity can be considered a sub-phenotype in 
the BN.GH18 rat strain, not secondary to hy-
pertension itself. This baroreceptor sensitivity 
may contribute to the development of hyper-
tension if placed in a susceptible background, 
but it may be compensated in the BN back-
ground.
In summary, our findings suggest that, 
for complex diseases such as hypertension, 
gene(s) from one candidate region may not 
be sufficient to independently cause a com-
plex phenotype and that genomic background 
also plays a significant and often ignored role. 
When dealing with complex phenotypes such 
as hypertension, analysis of multiple loci, re-
lated potential intermediate phenotypes, and 
their interactions may help us to understand 
pathways involved in their homeostasis. De-
spite the fact the single and multiple locus 
congenic rats did not show any alterations in 
blood pressure by isolating hypertension sus-
ceptible (GH) QTL on a normotensive back-
ground (BN), we were able to determine like-
ly intermediate phenotypes within the QTL 
that influence hypertension on chromosomes 
2 and 18 and to confirm the presence of genet-
ic determinants of the baroreceptor reflex on 
chromosome 18. Our future steps will include 
further evaluation of these genome regions, se-
lection of candidate genes followed by gene ex-
pression, and physiological studies.
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